Salute e Benessere

Shenzhen Hosts the 2nd AGP&DTx Summit Forum: Advancing Digital Therapeutics in…

At the conference, Professor Andrej Janež, Head of the Department of Endocrinology at the Ljubljana University Medical Centre in Slovenia, highlighted China's advancements in AGP clinical practice. He remarked, "They've developed an AGP training program, and they're moving into the area of researching and using AI to enhance diagnosis and guide treatment decisions, leading to better diabetes care and facilitating AGP applications." At the conference, ProfessorAndrej Janež, Head of…
PR Newswire
12/07/2024

TXOne Networks Welcomes Stephen Driggers as New Chief Revenue Officer

"We are very excited about everything that Stephen is bringing to our company as our new CRO," said Dr. Terence Liu, Chief Executive Officer, TXOne Networks. "He is an inspiring leader with proven results in a variety of environments, and his professionalism and personal integrity are obvious. His contributions to TXOne Networks and our customers will be far-reaching." "We are very excited about everything that Stephen is bringing to our company as our new CRO,"…
PR Newswire
12/07/2024

"Salvează o inimă" Association innovates fundraising campaigns by integrating AI…

"Artificial intelligence helps us make a real-time analysis of the situation in order to make rapid adjustments to the fundraising strategy, but it also allows us to offer donors information about the efficiency of the campaigns they have contributed to," Vlad Plăcintă, president of the "Salvează o inimă" Association said. "Artificial intelligence helps us make a real-time analysis of the situation in order to make rapid adjustments to the fundraising strategy, but it…
PR Newswire
12/07/2024

XRP Healthcare LLC Successfully Registers Trademark in the UAE, Strengthening…

Registration in Ugandais crucial for branding its future healthcare establishments across Africa with the XRP Healthcare logo, ensuring consistency and recognition. The new trademark in the UAE further solidifies XRP Healthcare's presence and safeguards its brand in a key international market. Registration inUgandais crucial for branding its future healthcare establishments acrossAfricawith the XRP Healthcare logo, ensuring consistency and recognition. The new trademark in the UAE...
PR Newswire
12/07/2024

Addex To Present at the Thirteenth London International Cough Symposium (13th…

Geneva, Switzerland, July 12, 2024-Addex Therapeutics(SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that Mikhail Kalinichev, Head of Translational Science, will present at the Thirteenth London International Cough Symposium taking place July 18 - 19, 2024 at Imperial College in London, U.K.In his presentation, scheduled for 12:00 CEST /...
Nasdaq GlobeNewswire
12/07/2024

Leqembi approved for the treatment of Alzheimer's disease in Israel

Leqembi selectively binds to soluble amyloid-beta (Aβ) aggregates (protofibrils[2]), as well as insoluble Aβ aggregates (fibrils) which are a major component of Aβ plaques in AD, thereby reducing both Aβ protofibrils and Aβ plaques in the brain. Leqembi is the world's first approved treatment shown to reduce the rate of disease progression and to slow cognitive and functional decline through this mechanism. Leqembi selectively binds to soluble amyloid-beta (Aβ) aggregates (protofibrils [2] ),...
PR Newswire
12/07/2024

Molecular Glues Clinical Trial Pipeline Appears Robust With 10+ Key Pharma…

Key Takeaways from the Molecular Glues Competitive Landscape Report Key Takeaways from the Molecular Glues Competitive Landscape Report Request a sample and discover the recent advances in molecular glues treatment @ Molecular Glues Competitive Landscape Report Molecular Glues Overview Molecular glues are a novel class of small molecules that facilitate the interaction between proteins, leading to the degradation or modulation of target proteins that are typically difficult to drug...
PR Newswire
11/07/2024

ESP prostheses training program

Press release Ecully, July 11, 2024 – 6.30 p.m. Spineway organizes hands-on training on total disc replacement with its ESP prostheses at IRCAD in StrasbourgThe Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, organized a hands-on training workshop entitled “Hands-on Total Disc Replacement featuring ESP technology” at the Institut de Recherche contre les Cancers de l'Appareil Digestif (IRCAD) in Strasbourg on June 28, 2024...
Nasdaq GlobeNewswire
11/07/2024

Cumulus Neuroscience to Join Bio-Hermes 2 Study with Funding from the Innovate…

Funded by Innovate UK's Small Business Research Initiative (SBRI), this award is focused on enabling organisations with select novel biomarkers to be evaluated as part of the Global Alzheimer's Platform Foundation (GAP) Bio-Hermes 2 Study. Cumulus will deploy AccelADx in the study, a novel, AI-enabled screening test that detects small, subtle changes in brain waves associated with memory recall. Bio-Hermes 2, which aims to generate data to accelerate the adoption and effective use of biomarkers…
PR Newswire
11/07/2024

Oxurion provides clarification on the agenda of the extraordinary general…

Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024Leuven, BELGIUM – July 11, 2024 – 6:00pm CET– Oxurion NV (Euronext Brussels: OXUR), an innovative biopharmaceutical company based in Leuven, announced today it has provided clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024 (theEGM ) as set out in the convening notice published on 5 July 2024 in accordance with...
Nasdaq GlobeNewswire
11/07/2024

Groupe Casino - Nombre de droits de vote et d'actions 30-06-2024

CASINO, GUICHARD-PERRACHON Société anonyme au capital de 3 957 404,44 € Siège social : 1, Cours Antoine Guichard 42000 Saint-Etienne 554 501 171 R.C.S. Saint-Etienne Informations relatives au nombre total de droits de vote et d'actions composant le capital social au 30 juin 2024(article 223-16 du Règlement Général de l'Autorité des Marchés Financiers)Nombre d'actions composant le capitalNombre total de droits de voteNombre total de droits de vote exerçables en...
Nasdaq GlobeNewswire
11/07/2024

Hormone Replacement Therapy Market Size to be Worth USD 38.8 billion by 2034…

The hormone replacement therapy (HRT) market is experiencing robust growth, driven by increasing awareness of aging-related health issues and the quest for improved quality of life. HRT involves the administration of hormones to alleviate symptoms associated with menopause, andropause, and other hormonal imbalances. The hormone replacement therapy (HRT) market is experiencing robust growth, driven by increasing awareness of aging-related health issues and the quest for improved quality of…
PR Newswire
11/07/2024

Virbac: Termination of the liquidity contract

TERMINATION OF THE LIQUIDITY CONTRACT We inform you of the termination of our liquidity contract since July 1 st, 2024.This contact was in place since February 19, 2019 and suspended since February 3 rd, 2023. A lifelong commitment to animal healthAt Virbac, we provide innovative solutions to veterinarians, farmers and animal owners in more than 100 countries around the world. Covering more than 50 species, our range of products and services enables us to diagnose, prevent and treat...
Nasdaq GlobeNewswire
11/07/2024

RFID in Pharmaceutical Market to reach USD 7.57 Bn at a CAGR of 7.5 percent by…

The segmentation by type, component, distribution channel, and application aids in understanding the target audience, emerging trends, and market composition. Primary and secondary research techniques are combined in research studies on the RFID in Pharmaceutical market. Both qualitative and quantitative analyses are employed using tools like SWOT, PESTLE, and Porter's Five Forces to guide investment and marketing decisions. The segmentation by type, component, distribution channel, and...
PR Newswire
11/07/2024

GLP-1 Analogues Market Forecast: USD 471.1 Billion by 2032 with a 33.2% CAGR |…

Browse in-depth TOC on "GLP-1 Analogues Market". Browse in-depth TOC on "GLP-1 Analogues Market". 405 - Tables 59 - Figures315 - Pages Ozempic Leads the Charge in the GLP-1 Analogue Market In 2023, Ozempic (semaglutide) dominated the GLP-1 Analogue market, buoyed by its significant revenue contribution and broad global application for diabetes treatment. Its market presence extends to obesity treatment under the brand Wegovy inBrazil, with a notable growth rate of...
PR Newswire
11/07/2024

Vendor Neutral Archive (VNA) Market to be Worth USD 1.3 billion by 2034, Growing…

With VNAs, clinical imaging information can be stored, handled, and archived from diverse sources, eliminating fragmented storage silos. By streamlining data control and making information accessible across healthcare organizations, this consolidation promotes interoperability. Integrated with Electronic Health Records (EHRs), VNAs allow doctors to access clinical photos on a patient's record without delay. By integrating seamlessly, scientists can improve their workflows and create improved…
PR Newswire
11/07/2024

Induced Pluripotent Stem Cells Market Size is Expected to Grow at a CAGR of 9.4%…

The utilization of iPSCs in drug discovery and disease modeling is being accelerated by excessive-throughput screening technologies. Aside from heart disease, liver failure, and diabetes, iPSCs are capable of creating organ replacements. By doing so, the donor organ shortage can be addressed and the impact on affected people can be enhanced. Several wound recuperation treatments are possible with iPSCs, including those that treat excessive burns and chronic ulcers. The utilization of iPSCs in...
PR Newswire
11/07/2024

Injectable Cytotoxic Drug Market to Progress at a CAGR of 6.8%, reaching USD…

The prevalence of cancer has been a key factor that drives the demand for many sectors. Various therapeutics and treatments are required to be given to cancer patients, which drives the demand for such therapies and treatments. The prevalence of cancer has been a key factor that drives the demand for many sectors. Various therapeutics and treatments are required to be given to cancer patients, which drives the demand for such therapies and treatments. The upsurge in rheumatoid arthritis and...
PR Newswire
11/07/2024

Energy Supplement Market Value Set to Total USD 69.4 Billion by 2034, Spurred by…

One of the prominent factors fueling growth of the energy supplement industry is the increasing awareness about health and fitness among consumers. Similarly, growing demand for convenient energy-boosting supplements is set to boost sales growth. One of the prominent factors fueling growth of the energy supplement industry is the increasing awareness about health and fitness among consumers. Similarly, growing demand for convenient energy-boosting supplements is set to boost sales growth...
PR Newswire
11/07/2024

TUMI INTRODUCES LPGA TOUR PRO NELLY KORDA AND PGA TOUR PRO LUDVIG ÅBERG AS THE…

As two of the most committed and celebrated names in golf, Korda and Åberg epitomize a relentless dedication to performance, unwavering drive, and extraordinary results – ideals that TUMI passionately infuses into every collection. The new ambassadors will exclusively carry TUMI luggage and backpacks on tour as the brand supports these players and their ambition to perfect their game. "I'm so excited to partner with TUMI as a global ambassador, representing the brand on tour and...
PR Newswire
11/07/2024

Newest Version of LifeSphere® Regulatory Platform Allows Organizations to…

The new LifeSphere Regulatory Platform ecosystem of products includes: The newLifeSphere Regulatory Platformecosystem of products includes: Industry leaders utilizing LifeSphere Regulatory can further power the platforms' capabilities withLifeSphere NavaX, ArisGlobal's next-generation cognitive computing engine, to leverage the latest GenAI and LLM features. Today, early adopters can leverage GenAI and LLM enhancements that are driving upwards of 50% efficiency gains, including: ...
PR Newswire
11/07/2024

IAS ANNOUNCES 2024 ME AND MY HEALTHCARE PROVIDER CAMPAIGN CHAMPIONS TO HONOR…

Despite a decrease in new acquisition rates, stigma and discrimination remain significant challenges in HIV care. According to the People Living with HIV Stigma Index 2.0 Global Report 2023[1], while 93.5% of respondents were receiving HIV treatment, a majority reported experiencing internalized stigma associated with their HIV status. Additionally, 3% of respondents faced stigma and discrimination from health facility staff and 26.9% admitted to interrupting or stopping their HIV treatment…
PR Newswire
11/07/2024

OKYO Pharma to Initiate Neuropathic Corneal Pain Trial for OK-101

Phase 2 randomized, placebo-controlled trial in neuropathic corneal pain (NCP) patients planned to begin in Q3, 2024OK-101 is believed to be the first IND clearance granted by FDA for a drug to begin clinical studies specifically to treat patients suffering with neuropathic corneal pain (NCP), a major unmet medical needOK-101 demonstrated statistically significant pain relief as measured by visual analogue scale (VAS) from Day 29 through the last study visit at Day 85 in a Phase 2...
Nasdaq GlobeNewswire
11/07/2024

Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference…

The event will be webcast live with dial-in details and webcast replays available on Zymeworks' website at http://ir.zymeworks.com/events-and-presentations. About Zymeworks Inc.Zymeworks is a global clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Zymeworks' mission is to make a meaningful difference in the lives of people impacted by difficult-to-treat cancers and other diseases. The...
Nasdaq GlobeNewswire
11/07/2024
Altri  Comunicati